Accuray

ARAY · NASDAQ

$0.142−$0.001 (−0.70%)TodayMarket closed ·
Prev close $0.143

About ARAY

Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

Employees
990
Headquarters
Madison, Wisconsin
Listed
Feb 8, 2007
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Accuray executives
NameTitleSince
Stephen La Neve—2025
Ali Pervaiz——
Leonel Peralta——
Sandeep Chalke——
Michael Murphy——
James Hindman——
Beverly Huss——
Anne Le Grand——
Steven Mayer——
Mika Nishimura——
Joseph Whitters——
Aman Patel—2024

Revenue by product and region

Fiscal year ended Jun 30, 2025: $458.50M total revenue

By product

  • Products$101.56M22.2%
  • Services$18.52M4.0%

By region

  • Europe, India, Middle East and Africa$144.26M31.5%
  • China$124.47M27.1%
  • Americas$88.77M19.4%
  • Japan$53.62M11.7%
  • Asia Pacific [Member]$47.38M10.3%

Similar companies

Companies in the same industry as Accuray

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.